Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.00901934562254004 -0.00901934562254004 0.00299378447791138
Stock impact report

Regenxbio files $300M mixed shelf offering [Seeking Alpha]

REGENXBIO Inc. (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
Company Research Source: Seeking Alpha
The offering may include common stock, preferred stock, debt securities, warrants, rights, or units, in one or more combinations and tranches. More on Regenxbio REGENXBIO's Late-Stage Pipeline Momentum Strengthens After Q3 Earnings Beat REGENXBIO Inc. (RGNX) Q3 2025 Earnings Call Transcript Regenxbio: Poised For Breakthrough With RGX-121 Gene Therapy In Hunter Syndrome REGENXBIO plans top-line RGX-202 Duchenne data release in early Q2 2026 while advancing toward 2027 commercial launch Regenxbio Q3 2025 Earnings Preview Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
RGNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RGNX alerts
Opt-in for
RGNX alerts

from News Quantified
Opt-in for
RGNX alerts

from News Quantified